©The Author(s) 2025.
World J Clin Oncol. Nov 24, 2025; 16(11): 111419
Published online Nov 24, 2025. doi: 10.5306/wjco.v16.i11.111419
Published online Nov 24, 2025. doi: 10.5306/wjco.v16.i11.111419
Table 2 Emerging interventions in pediatric leukemia
| Intervention | Agent | Clinical implications | Ref. |
| Lactoferrin | Bovine lactoferrin 200 mg/day | Prevents dysbiosis; reduced febrile neutropenia | Martyniak et al[20], 2023 |
| Melatonin | Melatonin (various) | Increased microbiome diversity | Martyniak et al[20], 2023 |
| Biomarkers | Quantitative polymerase chain reaction (Ruminococcaceae/Veillonella) | 91% specificity for neutropenia risk | Sørum et al[9], 2025 |
| VOC panel | Fecal VOC profiling | Predicts bloodstream infection 15 days pre-symptoms | van de Velde et al[4], 2022 |
| Autologous fecal microbiome transplantation | Patient’s own stool | Personalized microbiome recovery | Todor and Ichim[8], 2025 |
| Lactose-free diet | Conditioning/hematopoietic stem cell transplantation | Prevents Enterococcus blooms; reduced graft-versus-host disease | Muratore et al[19], 2022 |
| High-fiber diet | ≥ 5 g fiber/day | 27% reduced leukemia risk (epidemiological) | Kameri et al[10], 2024 |
- Citation: Roganovic J, Radosevic M, Dordevic A. Role of the gut microbiome in the development and prognosis of pediatric leukemia. World J Clin Oncol 2025; 16(11): 111419
- URL: https://www.wjgnet.com/2218-4333/full/v16/i11/111419.htm
- DOI: https://dx.doi.org/10.5306/wjco.v16.i11.111419